Skip to main content
Explore URMC

menu

Head and Neck Cancer: Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IV Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

Research Question:
Do the changes in a gene called TP53 influence the response to radiation therapy alone or radiation therapy in combination with cisplatin chemotherapy?

Basic Study Information

Purpose:
The purpose of this study is to compare two treatment approaches that are currently used after surgery for head and neck cancer. One approach is to administer radiation therapy alone. A second approach is to administer radiation therapy along with the chemotherapy drug, cisplatin.

Location: Cancer Center
Study Web URL:  https://clinicaltrials.gov/ct2/show/NCT02734537?term=ea3132&rank=1
Study Reference #: CHAN17022

Lead Researcher (Principal Investigator)

Lead Researcher: Ronald Maggiore

Study Contact Information

Study Coordinator: Park Bogan
Phone: (585) 276-4415
Email: Park_Bogan@URMC.Rochester.edu

Additional Study Details

Learn More About These Conditions

More information about Carcinoma, Squamous Cell

Return to Search